LifeMD, Inc. (NASDAQ:LFMDP) Short Interest Up 47.6% in December
LifeMD, Inc. (NASDAQ:LFMDP – Get Rating) saw a significant increase in short interest in the month of December. As of December 30th, there was short interest totalling 3,100 shares, an increase of 4
LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company’s Rapid Expansion Into Virtual Primary Care
NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Jessica Friedeman as Chief Marketing Offic
LifeMD, Inc. (NASDAQ:LFMDP) Sees Large Drop in Short Interest
LifeMD, Inc. (NASDAQ:LFMDP – Get Rating) saw a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 3,500 shares, a decline of 12.5
LifeMD, Inc. Ranked Number 140 Fastest Growing Company on Deloitte’s 2022 North America Technology Fast 500™
NEW YORK, Nov. 22, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced it ranked #140 on Deloitte's Technology Fast 500™, a ranking
LifeMD, Inc. to Participate in Upcoming Investor Conferences
NEW YORK, Nov. 18, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that LifeMD management will participate in the following upco
LifeMD, Inc. 8.875% CUM PFD A Declares $0.5547 Dividend
LifeMD, Inc. 8.875% CUM PFD A (NASDAQ:LFMDP) declares $0.5547/share quarterly dividend, in line with previous. Forward yield 15.91% Payable Oct. 17; for shareholders of record Oct. 7; ex-div Oct. 6.
LifeMD Appoints Bobby Jindal to the Board of Directors
NEW YORK, Sept. 20, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, is pleased to announce its appointment of Bobby Jindal, the 55th Governor of
LifeMD and Cleared Offer New Hope to Allergy Patients Through Strategic Partnership With Allergenis
NEW YORK, Aug. 22, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a rapidly growing direct-to-patient telehealth company, today announced that its wholly-owned allergy telehealth subsidiary, Cleared, has entered into a strategic partnership with
LifeMD, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 11, 2022
NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that it will report its financial results for the sec
LifeMD Announces Continued and Rapid Expansion of Virtual Primary Care To over 200 Conditions
LifeMD's Virtual Primary Care platform now addresses over 200 conditions with its robust infrastructure of doctors, medical professionals, pharmacies, and lab testing capabilities.NEW YORK, July 19,
Loading...
No Stock Yet